Agilon Health AGL Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -7.5%+0.3pp | -7.8%-1.4pp | -6.4%0.0pp | -6.4%-1.3pp | -5.1%-0.3pp | |
| Net margin | -6.1%+0.5pp | -6.6%-1.4pp | -5.2%+0.1pp | -5.3%-1.3pp | -4%+0.3pp | |
| Returns | ||||||
| Return on equity | -104%+26.9pp | -131%-61.0pp | -70%-11.8pp | -58.2%-17.5pp | -40.7%+5.2pp | |
| Efficiency | ||||||
| Asset turnover | 3.4×-0.6× | 3.9×+0.8× | 3.2×+0.1× | 3×+0.2× | 2.8×-0.7× | |
| Liquidity | ||||||
| Current ratio | 1×0.0× | 1×-0.1× | 1.1×-0.1× | 1.2×0.0× | 1.2×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×-0.1× | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $10.89+3,457% | $0.31-58.6% | $0.74-25.3% | $0.99-96.7% | $30.29+2,543% | |
| Valuation | ||||||
| Market capitalization | $131.26M-54.0% | $285.52M-33.1% | $426.86M-53.3% | $914.83M-48.8% | $1.79B+128% | |
| Price / sales | 0×0.0× | 0×0.0× | 0.1×-0.1× | 0.2×-0.1× | 0.3×+0.2× | |
| Price / book | 0.7×-1.5× | 2.3×+0.9× | 1.4×-0.8× | 2.2×-1.3× | 3.6×+1.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Agilon Health's ratios come from?
- Every ratio is computed from Agilon Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.